Listed

Genmab A/S

GMABNasdaqCIK 1434265Healthcare

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$1.72bn, FY2025
Shareholders' equity$5.85bn, FY2025
Line itemUnitperiod not labelled2022-12-31period not labelled2023-12-31period not labelled2024-12-31FY20252025-12-31
Cash and equivalents$bn1.4Cash and equivalents, period not labelled, at 2022-12-31$1.42bn. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure2.2Cash and equivalents, period not labelled, at 2023-12-31$2.20bn. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure1.4Cash and equivalents, period not labelled, at 2024-12-31$1.38bn. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure1.7Cash and equivalents, FY2025, at 2025-12-31$1.72bn. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure
Current assets$bnnot reported4.9Current assets, period not labelled, at 2023-12-31$4.91bn. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure3.9Current assets, period not labelled, at 2024-12-31$3.90bn. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure2.9Current assets, FY2025, at 2025-12-31$2.88bn. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure
Total assets$bnnot reported5.2Total assets, period not labelled, at 2023-12-31$5.23bn. XBRL concept ifrs-full:Assets. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure6.4Total assets, period not labelled, at 2024-12-31$6.41bn. XBRL concept ifrs-full:Assets. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure12.9Total assets, FY2025, at 2025-12-31$12.87bn. XBRL concept ifrs-full:Assets. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure
Current liabilities$bnnot reported0.4Current liabilities, period not labelled, at 2023-12-31$368.0m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure0.7Current liabilities, period not labelled, at 2024-12-31$744.0m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure1.4Current liabilities, FY2025, at 2025-12-31$1.43bn. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure
Total liabilities$bnnot reported0.5Total liabilities, period not labelled, at 2023-12-31$545.0m. XBRL concept ifrs-full:Liabilities. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure1.3Total liabilities, period not labelled, at 2024-12-31$1.28bn. XBRL concept ifrs-full:Liabilities. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure7.0Total liabilities, FY2025, at 2025-12-31$7.03bn. XBRL concept ifrs-full:Liabilities. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure
Shareholders' equity$bn3.9Shareholders' equity, period not labelled, at 2022-12-31$3.92bn. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure4.7Shareholders' equity, period not labelled, at 2023-12-31$4.69bn. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure5.1Shareholders' equity, period not labelled, at 2024-12-31$5.14bn. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure5.8Shareholders' equity, FY2025, at 2025-12-31$5.85bn. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-17, accession 0001434265-26-000014.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.